REGISTER NOW FOR THIS EVENT Advanced FHIR training: How to track changes on a medicinal product? UNICOM is happy to invite all of you to the 4th NCA FHIR training on […]
Agenda: Introduction to Fimea Medicinal product database demo Lessons learned Priority actions expected from EMA Speakers: Joonas Tuominen (Fimea) Anu Ollikainen (Fimea) Markus Mäkelä (Fimea) Juha Jokimäki (Solita Finland Oy)
Unicom will be presenting all the results of WP2 related to SUBSTANCES
Annet ROSEMA from CBG in the Netherlands, Christian HAYE from GS1 and Frit Stulp will represent UNICOM during this event where UNICOM will be the red string of most strategic […]
Across the UNICOM project we have been actively developing a number of standards-based resources, including FHIR Implementation Guides, a Product Lifecycle Management portal (with EMA), an IDMP database, a substitution […]
For National Competent Authorities, IDMP implementation is not an option and is already legally compulsory for pharmacovigilance. Industry has already started to submit data in the IDMP format for CAP […]
UNICOM Day - ensure that any medicine and what it contains can be accurately identified anywhere in the world. Improve patient safety and enable better healthcare for all Agenda: 9:30 […]
The webinar is opened to all the staff of all Medicinal Products Agencies. If you want to be invited, send a mail to 1 Welcome: Georg, Sonja Noel 2: […]
This year’s ePI Summit was hosted by ROTE LISTE®. In an era where innovation is transforming every industry, the pharmaceutical sector is no exception. This year’s summit has explored the latest […]
The UNICOM project has been working to improve patient safety and enable better healthcare for all, through the implementation of IDMP related standards and terminologies within a variety of processes […]
Breakthrough 2024 is the must-attend event for life sciences leaders across the globe. It’s the one place where leaders like you engage in the brightest, forward-looking life sciences industry conversations […]
The UNICOM Innovation Action has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 875299.
